19816/34347US=108 / Câncer
Schirrmacher V, Fournier P. Newcastle disease virus: a promising vector for viral therapy of cancer. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 171-86. ISBN 978-0-470-01922-1.

CANCER. TRATAMENTO; VIRUS DA DOENCA DE NEWCASTLE


19817/34347US=108 / Câncer
Bell J, Parato K, Atkins H. Vesicular stomatitis virus. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 187-203. ISBN 978-0-470-01922-1.

VIRUS DA ESTOMATITE VESICULAR; CICLO CELULAR; PATOGENESE; INTERFERON; RESPOSTA IMUNE


19818/34347US=108 / Câncer
Fielding A. Measles as an oncolytic virus. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 205-15. ISBN 978-0-470-01922-1.

VIRUS ONCOLITICO; VIRUS DO SARAMPO; VACINA; RECEPTORES; SISTEMA IMUNE


19819/34347US=108 / Câncer
Yamanaka R. Alphaviruses. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 217-28. ISBN 978-0-470-01922-1.

ALFAVIRUS; VIRUS RNA; CICLO DE VIDA; VACINA; VETOR ALFAVIRUS


19820/34347US=108 / Câncer
Fang B, Roth JA. Tumour-suppressor gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 229-39. ISBN 978-0-470-01922-1.

TERAPIA GENICA; GENE SUPRESSOR DE TUMOR; CANCER. TRATAMENTO; GENE P53


19821/34347US=108 / Câncer
Moss C, Lemoine N. RNA interference and dominant negative approaches. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 241-54. ISBN 978-0-470-01922-1.

RNA DE INTERFERENCIA; AGENTES OLIGONUCLEOTIDEOS; RNAI; ANTISENSE


19822/34347US=108 / Câncer
Schepelmann S, Hedley D, Ogilvie LM, Springer CJ. Gene-directed enzyme prodrug therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 255-76. ISBN 978-0-470-01922-1.

TERAPIA GENICA; PRO-DROGA; PRO-FARMACO ATIVADO POR ENZIMA; GANCICLOVIR; TIMIDINA QUINASE; 5-FLUOROCITOSINA; CITOSINA DEAMINASE; CB1954; NITRORREDUTASE; CARBOXIPEPTIDASE G2; OXAZAPHOSPHORINES; CITOCROMO P450; FLUDARABINA; PURINA NUCLEOSIDEO FOSFORILASE; SELENOMETIONINA; METIONINASE; CPT-11; CARBOXILESTERASE; RETROVIRUS; ADENOVIRUS; VACCINIA; VIRUS HERPES SIMPLEX; VIRUS SINDBIS


19823/34347US=103 / Câncer
O´Donnell JL, Shannon AM, Bouchier-Hayes D. Tumour hypoxia: malignant mediator. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 245-61. ISBN 978-0-470-72303-6.

HIPOXIA; HIPOXIA INDUZIDA POR FATOR 1; HIF-1ALFA


19824/34347US=103 / Câncer
O´Connor R, Breen L. Resistance to chemotherapy drugs. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 263-81. ISBN 978-0-470-72303-6.

QUIMIOTERAPIA; RESISTENCIA AOS FARMACOS; RESISTENCIA AOS MECANISMOS DE QUIMIOTERAPIA; RESISTENCIA FARMACOCINETICA; RESISTENCIA FARMACODINAMICA


19825/34347US=103 / Câncer
Belimezi M. Cancer immunotherapy. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 283-304. ISBN 978-0-470-72303-6.

CANCER; IMUNOTERAPIA; BASE MOLECULAR DA IMUNOTERAPIA; ANTICORPOS MONOCLONAIS RECOMBINANTES; IMUNOTERAPIA CELULAR; VACINAS


19826/34347US=108 / Câncer
Boulanger D, Bateman A. Immunomodulatory gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 277-94. ISBN 978-0-470-01922-1.

TERAPIA GENICA; IMUNOMODULADORES; IMUNOTERAPIA; VETORES VIRAIS; TERAPIA DO GENE SUICIDA; VIROTERAPIA; POXVIRUS; VIRUS VACCINIA; AVIPOXVIRUS; ADENOVIRUS; ALPHAVIRUS; VIRUS SEMLIKI FOREST; VIRUS SINDBIS; VIRUS HERPES; ANTIGENO CARCINOEMBRIONARIO; MELANOMA; TIROSINASE; GP100; CANCER COLORRETAL; CANCER DE PROSTATA; PAPILOMAVIRUS HUMANO; HPV


19827/34347US=103 / Câncer
Belimezi M, Boulikas T, Roberts ML. Gene therapy. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 305-16. ISBN 978-0-470-72303-6.

CANCER; TERAPIA GENICA; RETROVIRUS; ADENOVIRUS; IMUNOTERAPIA; GENES DE CITOCINAS; IL-12; ADENOVIRUS ONCOLITICOS


19828/34347US=108 / Câncer
Tandle AT, Libutti SK. Antiangiogenic gene delivery. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 295-312. ISBN 978-0-470-01922-1.

GENE ANTIANGIOGENICO; ANGIOGENESE; TUMOR VASCULAR; ADENOVIRUS; RETROVIRUS; LENTIVIRUS; HERPES SIMPLEX; VETORES DE BACTERIOFAGOS


19829/34347US=103 / Câncer
Khan H, Missailidis S. Antisense agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 317-30. ISBN 978-0-470-72303-6.

AGENTES ANTI-SENTIDO; OLIGONUCLEOTIDOS ANTI-SENTIDO; RIBOZIMAS; DNAZIMAS; RNA DE INTERFERENCIA; SIRNA


19830/34347US=108 / Câncer
Veerapong J, Bickenbach KA, Weichselbaum RR. Radiosensitization in viral gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 313-26. ISBN 978-0-470-01922-1.

TERAPIA GENICA; RADIOSENSIBILIZACAO; ADENOVIRUS; VIRUS HERPES SIMPLEX; TIMIDINE QUINASE; CITOSINA DEAMINASE; NITRORREDUTASE; CITOCROMO P450; TERAPIA DE GENE SUICIDA


19831/34347US=103 / Câncer
Makwana V, Simmons S, Missailidis S. Aptamers as anticancer agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 331-45. ISBN 978-0-470-72303-6.

AGENTES ANTICANCERIGENOS; APTAMEROS; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; NUCLEOLIN; PROTEINA E2F; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; ANTIGENO PROSTATICO ESPECIFICO DE MEMBRANA


19832/34347US=108 / Câncer
Peerlinck IDL, Vassaux G. Radioisotope delivery. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 327-40. ISBN 978-0-470-01922-1.

TERAPIA GENICA; RADIOISOTOPOS; TERAPIA COM IODO; TIREOIDE; MAMA


19833/34347US=103 / Câncer
Smith GR. Treatment of cancer in conjunction with other agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 349-64. ISBN 978-0-470-72303-6.

CANCER. TRATAMENTO; AGENTES ANTI-INFLAMATORIOS; AGENTES ANTI-INFECCIOSOS; CARCINOGENESE; ANTI-INFLAMATORIOS NAO-ESTEROIDES; ENZIMA CONVERSORA DE ANGIOTENSINA (ECA); BLOQUEIO DO RECEPTOR DE ANGIOTENSINA


19834/34347US=103 / Câncer
Friede T, Dunn J, Stallard N. Clinical trials in oncology. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 365-75. ISBN 978-0-470-72303-6.

CANCER; ONCOLOGIA; ENSAIOS CLINICOS


19835/34347US=108 / Câncer
Greenberger JS, Epperly MW. Radioprotective gene therapy: current status and future goals. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 341-75. ISBN 978-0-470-01922-1.

TERAPIA GENICA RADIOPROTETORA; CAVIDADE ORAL; OROFARINGE; MNSOD-PL; LIPOSSOMAS DE MANGANES SUPEROXIDO DISMUTASE PLASMIDEO; IRRADIACAO PULMONAR


Primeira | Anterior | Próxima | Última